Dr. med. Gerald Wulf

Name Card

Main Affiliation
 
Staff Status
unigoe
 

1-55 of 55
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2022 | Journal Article | Research Paper | 
    ​ ​Koenig, J. F. L., Asendorf, T., Simon, A., Bleckmann, A., Trümper, L., Wulf, G. G. & Overbeck, T. R. (2022). ​“SpezPat”- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians’ understanding of non-small cell lung cancer patients’ end-of-life decisions. BMC Palliative Care, 21(1), Article 167​. ​doi: https://doi.org/10.1186/s12904-022-01057-5 
    ​Details  DOI 
  • 2022 | Journal Article | Research Paper | 
    ​ ​Shumilov, E., Aperdannier, L., Schmidt, N., Szuszies, C., Neesse, A., Hoffknecht, P., Khandanpour, C. ... Bleckmann, A. (2022). ​Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis. Cancers, 14(15), . ​doi: https://doi.org/10.3390/cancers14153746 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​Shumilov, E., Hasenkamp, J., Maulhardt, M., Mazzeo, P., Schmidt, N., Boyadzhiev, H., Jung, W. ... Wulf, G. (2022). ​Outcomes of second allogeneic stem cell transplantation and anti‐relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis. Hematological Oncology, 40(4), ​763​-776​. ​doi: https://doi.org/10.1002/hon.2995 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​Neuchel, C., Gowdavally, S., Tsamadou, C., Platzbecker, U., Sala, E., Wagner‐Drouet, E., Valerius, T. ... Fürst, D. (2022). ​Higher risk for chronic graft‐versus‐host disease ( GvHD ) in HLA‐G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective study. HLA, Article tan.14733​. ​doi: https://doi.org/10.1111/tan.14733 
    ​Details  DOI 
  • 2022 | Journal Article | Research Paper | 
    ​ ​Aydilek, E., Jäger, K., Xhaxho, K., Akdas, R., Wallbach, M., Wulf, G. & Brökers, N. (2022). ​Hypernatriämie und Polyurie bei einer Patientin mit Erstdiagnose einer sekundären akuten myeloischen Leukämie. Die Innere Medizin, 63(11), ​1194​-1199​. ​doi: https://doi.org/10.1007/s00108-022-01381-1 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​Tsamadou, C., Gowdavally, S., Platzbecker, U., Sala, E., Valerius, T., Wagner-Drouet, E., Wulf, G. ... Fuerst, D. (2022). ​Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation. Bone Marrow Transplantation, . ​doi: https://doi.org/10.1038/s41409-022-01751-1 
    ​Details  DOI 
  • 2021 | Journal Article | 
    ​ ​Mytilineos, D., Tsamadou, C., Neuchel, C., Platzbecker, U., Bunjes, D., Schub, N., Wagner-Drouet, E. ... Mytilineos, J. (2021). ​The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis. Frontiers in Immunology, 11, . ​doi: https://doi.org/10.3389/fimmu.2020.614976 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Hirschbühl, K., Labopin, M., Houhou, M., Gabellier, L., Labussière-Wallet, H., Lioure, B., Beelen, D. ... Mohty, M. (2020). ​Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transplantation, . ​doi: https://doi.org/10.1038/s41409-020-01173-x 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Werhahn, S. M., Wulf, G., Hasenfuß, G. & Hellenkamp, K. (2020). ​Acute right ventricular failure caused by extensive cardiac infiltration of T-cell acute lymphoblastic leukaemia. European Heart Journal - Cardiovascular Imaging, 21(6), ​682​-682​. ​doi: https://doi.org/10.1093/ehjci/jeaa007 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Beelen, D. W., Trenschel, R., Stelljes, M., Groth, C., Masszi, T., Reményi, P., Wagner-Drouet, Eva-Maria ... Markiewicz, M. (2020). ​Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial. The Lancet Haematology, 7(1), ​e28​-e39​. ​doi: https://doi.org/10.1016/S2352-3026(19)30157-7 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​McLornan, D. P., Malpassuti, V., Lippinkhof‐Kozijn, A., Potter, V., Beelen, D., Bunjes, D., Sengeloev, H. ... Yakoub‐Agha, I. (2020). ​Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT. British Journal of Haematology, 190(3), ​437​-441​. ​doi: https://doi.org/10.1111/bjh.16537 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Penack, O., Peczynski, C., van der Werf, S., Finke, J., Ganser, A., Schoemans, H., Pavlu, J. ... Basak, G. W. (2020). ​Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party. Frontiers in Immunology, 11, . ​doi: https://doi.org/10.3389/fimmu.2020.00586 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Kapp-Schwoerer, S., Weber, D., Corbacioglu, A., Gaidzik, V. I., Paschka, P., Krönke, J., Theis, F. ... Döhner, K. (2020). ​Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1 -mutated AML: results from the AMLSG 09-09 trial. Blood, 136(26), ​3041​-3050​. ​doi: https://doi.org/10.1182/blood.2020005998 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Frankiewicz, A., Peczynski, C., Giebel, S., Harrington, A., Socié, G., Niederwieser, D., Scheid, C. ... Basak, G. W. (2020). ​Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT. Frontiers in Immunology, 11, . ​doi: https://doi.org/10.3389/fimmu.2020.01537 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Li, W., Stauske, M., Luo, X., Wagner, S., Vollrath, M., Mehnert, C. S., Schubert, M. ... Guan, K. (2020). ​Disease Phenotypes and Mechanisms of iPSC-Derived Cardiomyocytes From Brugada Syndrome Patients With a Loss-of-Function SCN5A Mutation. Frontiers in Cell and Developmental Biology, 8, . ​doi: https://doi.org/10.3389/fcell.2020.592893 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Ziepert, M., Lazzi, S., Santi, R., Vergoni, F., Granai, M., Mancini, V., Staiger, A. ... Leoncini, L. (2020). ​A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients. Haematologica, 105(11), ​2667​-2670​. ​doi: https://doi.org/10.3324/haematol.2019.235556 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Wulf, G. G., Altmann, B., Ziepert, M., D’Amore, F., Held, G., Greil, R., Tournilhac, O. ... Trümper, L. (2020). ​Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial. Leukemia, . ​doi: https://doi.org/10.1038/s41375-020-0838-5 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Schlenk, R. F., Paschka, P., Krzykalla, J., Weber, D., Kapp-Schwoerer, S., Gaidzik, V. I., Leis, C. ... Döhner, H. (2020). ​Gemtuzumab Ozogamicin in NPM1 -Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study. Journal of Clinical Oncology, 38(6), ​623​-632​. ​doi: https://doi.org/10.1200/JCO.19.01406 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Penack, O., Peczynski, C., van der Werf, S., Finke, J., Ganser, A., Schoemans, H., Pavlu, J. ... Basak, G. W. (2020). ​Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation – a prospective, non-interventional study of the EBMT Transplant Complication Working Party. Haematologica, 105(7), ​1977​-1983​. ​doi: https://doi.org/10.3324/haematol.2019.228668 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Sellner, L., Schetelig, J., Koster, L., Choi, G., Blaise, D., Beelen, D., Schianca, F. C. ... Dreger, P. (2020). ​Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey. Bone Marrow Transplantation, 55(12), ​2335​-2338​. ​doi: https://doi.org/10.1038/s41409-020-0946-x 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​König, J., Gerst, C., Trümper, L., Wulf, G. G. & Wiesemann, C. (2020). ​Am individuellen Therapieergebnis orientierte Erstattungsverfahren in der Onkologie: ethische Implikationen am Beispiel der CAR-T-Zelltherapie. Ethik in der Medizin, 32(1), ​85​-92​. ​doi: https://doi.org/10.1007/s00481-020-00565-3 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Bleckmann, A., Dierks, S., Schildhaus, Hans-Ulrich, Hellige, N., Bacher, U., Trümper, L. & Wulf, G. (2020). ​Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation. Annals of Hematology, . ​doi: https://doi.org/10.1007/s00277-020-03974-y 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Mika, T., Maghnouj, A., Klein-Scory, S., Ladigan-Badura, S., Baraniskin, A., Thomson, J., Hasenkamp, J. ... Schroers, R. (2020). ​Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells. Frontiers in Molecular Biosciences, 7, . ​doi: https://doi.org/10.3389/fmolb.2020.00084 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Zettl, F., Ziepert, M., Altmann, B., Zeynalova, S., Held, G., Pöschel, V., Hohloch, K. ... Trümper, L. (2020). ​Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group). Annals of Hematology, 100(4), ​1031​-1038​. ​doi: https://doi.org/10.1007/s00277-020-04345-3 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Wulf, G. & Weber, T. (2019). ​Periphere T‑Zell-Lymphome. Der Onkologe, 25(10), ​892​-898​. ​doi: https://doi.org/10.1007/s00761-019-0636-8 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Schlenk, R. F., Weber, D., Fiedler, W., Salih, H. R., Wulf, G., Salwender, H., Schroeder, T. ... Döhner, H. (2019). ​Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD. Blood, 133(8), ​840​-851​. ​doi: https://doi.org/10.1182/blood-2018-08-869453 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Michallet, M., Dreger, P., Sobh, M., Koster, L., Hoek, J., Boumendil, A., Scheid, C. ... Schetelig, J. (2019). ​Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia. Bone Marrow Transplantation, 55(5), ​884​-890​. ​doi: https://doi.org/10.1038/s41409-019-0742-7 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Wiktor-Jedrzejczak, W., Drozd-Sokolowska, J., Eikema, D. J., Hoek, J., Potter, M., Wulf, G., Sellner, L. ... Dreger, P. (2019). ​EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL). Bone Marrow Transplantation, 54(9), ​1391​-1398​. ​doi: https://doi.org/10.1038/s41409-019-0448-x 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Mika, T., Baraniskin, A., Ladigan, S., Wulf, G., Dierks, S., Haase, D., Schork, K. ... Klein‐Scory, S. (2019). ​Digital droplet PCR‐based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation. International Journal of Laboratory Hematology, 41(5), ​615​-621​. ​doi: https://doi.org/10.1111/ijlh.13073 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Ripperger, T., Hofmann, W., Koch, J. C., Shirneshan, K., Haase, D., Wulf, G., Issing, P. R. ... Steinemann, D. (2018). ​MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies. Haematologica, 103(2), ​e55​-e58​. ​doi: https://doi.org/10.3324/haematol.2017.178723 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Kröger, N., Eikema, D., Köster, L., Beelen, D., de Wreede, L. C., Finke, J., Koenecke, C. ... Robin, M. (2018). ​Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia. British Journal of Haematology, 185(4), ​725​-732​. ​doi: https://doi.org/10.1111/bjh.15819 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Venkataramani, V., Doeppner, T. R., Willkommen, D., Cahill, C. M., Xin, Y., Ye, G., Liu, Y. ... Rogers, J. T. (2018). ​Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H-Ferritin. Journal of Neurochemistry, 147(6), ​831​-848​. ​doi: https://doi.org/10.1111/jnc.14580 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​d'Amore, F., Leppä, S., Silva, M. G. da, Relander, T., Lauritzsen, G. F., Brown, P. D. N., Pezzutto, A. ... Toldbod, H. (2018). ​Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant. Blood, 132(Supplement 1), ​998​-998​. ​doi: https://doi.org/10.1182/blood-2018-99-110429 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Paschka, P., Schlenk, R. F, Weber, D., Benner, A., Bullinger, L., Heuser, M., Gaidzik, V. I ... Döhner, H. (2018). ​Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial. Leukemia, 32(7), ​1621​-1630​. ​doi: https://doi.org/10.1038/s41375-018-0129-6 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Wulf, G., Hasenkamp, J., Jung, W., Wilhelm, C., Held, G., Nickelsen, M., Leha, A. ... Glass, B. (2018). ​Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease. Bone Marrow Transplantation, 54(6), ​877​-884​. ​doi: https://doi.org/10.1038/s41409-018-0360-9 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Schlenk, R. F., Paschka, P., Krzykalla, J., Weber, D., Kapp-Schwoerer, S., Gaidzik, V. I., Leis, C. ... Döhner, H. (2018). ​Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia (AML): Results from the Prospective Randomized AMLSG 09-09 Phase-III Study. Blood, 132(Supplement 1), ​81​-81​. ​doi: https://doi.org/10.1182/blood-2018-99-113442 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Robinson, S., Boumendil, A., Finel, H., Khvedelidze, I., Kanfer, E., Peggs, K., Furst, S. ... Montoto, S. (2018). ​Donor Lymphocyte Infusions for the Treatment of Relapsed Non-Hodgkin Lymphoma Following Allogeneic Stem Cell Transplantation: A LWP-EBMT Study. Blood, 132(Supplement 1), ​707​-707​. ​doi: https://doi.org/10.1182/blood-2018-99-113906 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Kroeger, N., Sockel, K., Wolschke, C., Bethge, W., Schlenk, R. F., Wolf‎, D., Stadler, M. ... Platzbecker, U. (2018). ​Prospective Multicenter Phase 3 Study Comparing 5-Azacytidine (5-Aza) Induction Followed By Allogeneic Stem Cell Transplantation Versus Continuous 5-Aza According to Donor Availability in Elderly MDS Patients (55-70 years) (VidazaAllo Study). Blood, 132(Supplement 1), ​208​-208​. ​doi: https://doi.org/10.1182/blood-2018-99-115932 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Theis, F., Weber, D., Rücker, F. G., Paschka, P., Gaidzik, V. I., Thol, F., Heuser, M. ... Döhner, K. (2018). ​Monitoring of FLT3 Phosphorylation and FLT3 Ligand Levels in Patients with FLT3-ITD Mutated Acute Myeloid Leukemia (AML) Treated with Midostaurin within the AMLSG 16-10 Trial of the German-Austrian Study Group. Blood, 132(Supplement 1), ​1501​-1501​. ​doi: https://doi.org/10.1182/blood-2018-99-114588 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Kapp-Schwoerer, S., Weber, D., Corbacioglu, A., Gaidzik, V. I., Paschka, P., Krönke, J., Teleanu, Maria-Veronica ... Döhner, K. (2018). ​Assessment of Treatment Effects By Measurable Residual Disease Monitoring in NPM1-Mutated AML Patients Randomized for Gemtuzumab-Ozogamicin (GO) within the AMLSG 09-09 Trial of the German-Austrian AML Study Group (AMLSG). Blood, 132(Supplement 1), ​991​-991​. ​doi: https://doi.org/10.1182/blood-2018-99-114648 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Dreger, P., Michallet, M., Bosman, P., Dietrich, S., Sobh, M., Boumendil, A., Nagler, A. ... Schetelig, J. (2018). ​Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties. Bone Marrow Transplantation, 54(1), ​44​-52​. ​doi: https://doi.org/10.1038/s41409-018-0207-4 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Shahnaz Syed Abd Kadir, S., Christopeit, M., Wulf, G., Wagner, E., Bornhauser, M., Schroeder, T., Crysandt, M. ... Kröger, N. (2018). ​Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis. European Journal of Haematology, 101(3), ​305​-317​. ​doi: https://doi.org/10.1111/ejh.13099 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Venkataramani, V., Küffer, S., Cheung, K. C., Jiang, X., Trümper, L., Wulf, G. G. & Ströbel, P. (2018). ​CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas. Clinical Cancer Research, 24(2), ​460​-473​. ​doi: https://doi.org/10.1158/1078-0432.CCR-17-1778 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Oyekunle, A., Shumilov, E., Kostrewa, P., Burchert, A., Trümper, L., Wuchter, P., Wulf, G. ... Kröger, N. (2018). ​Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens. Biology of Blood and Marrow Transplantation, 24(2), ​276​-281​. ​doi: https://doi.org/10.1016/j.bbmt.2017.10.008 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Shumilov, E., Bacher, U., Perske, C., Mohr, A., Eiffert, H., Hasenkamp, J., Trümper, L. ... Venkataramani, V. (2018). ​In Situ Validation of the Endothelial Cell Receptor GRP78 in a Case of Rhinocerebral Mucormycosis. Antimicrobial Agents and Chemotherapy, 62(5), . ​doi: https://doi.org/10.1128/AAC.00172-18 
    ​Details  DOI 
  • 2018 | Journal Article | Research Paper
    ​ ​Chapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S. ... Shipp, M. A. (2018). ​Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nature Medicine, 24(5), ​679​-690​. ​doi: https://doi.org/10.1038/s41591-018-0016-8 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Mytilineos, D., Fuerst, D., Niederwieser, D., Neuchel, C., Bunjes, D., Tsamadou, C., Gramatzki, M. ... Mytilineos, J. (2017). ​P043 HLA-DPB matching and donor cytomegalovirus positive (CMV+) status: An “unconventional alliance” associated with a decreased relapse incidence in unrelated hematopoietic stem cell transplantation (UHSCT). Human Immunology, 78, ​86​. ​doi: https://doi.org/10.1016/j.humimm.2017.06.103 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Nagel, G., Weber, D., Fromm, E., Erhardt, S., Lübbert, M., Fiedler, W., Kindler, T. ... Schlenk, R. F. (2017). ​Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO). Annals of Hematology, 96(12), ​1993​-2003​. ​doi: https://doi.org/10.1007/s00277-017-3150-3 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Shumilov, E., Wulf, G., Ströbel, P., Hasenkamp, J., Hellige, N., Bleckmann, A., Haase, D. ... Bacher, U. (2016). ​Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib. Leukemia & Lymphoma, 57(10), ​2476​-2480​. ​doi: https://doi.org/10.3109/10428194.2016.1151510 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Kröger, N., Eikema, Diderik-Jan, De Wreede, L., van Biezen, A., Beelen, D. W., Finke, J., Koenecke, C. ... Robin, M. (2016). ​Comparison of Allogeneic Stem Cell Transplantation for Transformed Acute Myeloid Leukemia Derived from MDS, CMML or MPN. a Report of the Chronic Malignancies Working Party of EBMT. Blood, 128(22), ​3499​-3499​. ​doi: https://doi.org/10.1182/blood.V128.22.3499.3499 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Schlenk, R. F., Fiedler, W., Salih, H. R., Wulf, G., Thol, F., Kündgen, A., Kindler, T. ... Döhner, H. (2016). ​Impact of Age and Midostaurin-Dose on Response and Outcome in Acute Myeloid Leukemia with FLT3-ITD: Interim-Analyses of the AMLSG 16-10 Trial. Blood, 128(22), ​449​-449​. ​doi: https://doi.org/10.1182/blood.V128.22.449.449 
    ​Details  DOI 
  • 2013 | Journal Article | Research Paper
    ​ ​Streckfuss-Boemeke, K., Wolf, F., Azizian, A., Stauske, M., Tiburcy, M., Wagner, S., Huebscher, D. ... Guan, K. (2013). ​Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. European heart journal, 34(33), ​2618​-2629​. ​doi: https://doi.org/10.1093/eurheartj/ehs203 
    ​Details  DOI  PMID  PMC  WoS 
  • 2009 | Journal Article | Research Paper
    ​ ​Piesche, M., Hildebrandt, Y., Chapuy, B., Wulf, G. G., Truemper, L. H. & Schroers, R. (2009). ​Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3. Vaccine, 27(34), ​4718​-4723​. ​doi: https://doi.org/10.1016/j.vaccine.2009.05.010 
    ​Details  DOI  PMID  PMC  WoS 
  • 2005 | Journal Article | Research Paper
    ​ ​Wulf, G. G., Hasenkamp, J., Jung, W., Chapuy, B., Truemper, L. H. & Glass, B. (2005). ​Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma. Bone Marrow Transplantation, 36(3), ​271​-273​. ​doi: https://doi.org/10.1038/sj.bmt.1705036 
    ​Details  DOI  PMID  PMC  WoS 
  • 2004 | Journal Article | Research Paper
    ​ ​Höcht-Zeisberg, E., Kahnert, H., Guan, K., Wulf, G., Hemmerlein, B., Schlott, T., Tenderich, G. ... Hasenfuß, G. (2004). ​Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. European heart journal, 25(9), ​749​-758​. ​doi: https://doi.org/10.1016/j.ehj.2004.01.017 
    ​Details  DOI  PMID  PMC  WoS 

Publication List

All Articles (Book & Journal) Articles & Preprints Papers (Journal & Conference)

Type

Subtype

Date issued

Author

Project

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver
https://publications.goettingen-research-online.de URI: /cris/rp/rp34512
ID: 0000000
PREF: apa TOKEN:

0

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.